Genesystem Co., Ltd. (KOSDAQ:363250)

Genesystem Statistics

Total Valuation

Genesystem has a market cap or net worth of KRW 32.60 billion. The enterprise value is 34.75 billion.

Market Cap	32.60B
Enterprise Value	34.75B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genesystem has 6.82 million shares outstanding. The number of shares has decreased by -1.98% in one year.

Current Share Class	6.82M
Shares Outstanding	6.82M
Shares Change (YoY)	-1.98%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	19.40%
Owned by Institutions (%)	16.75%
Float	5.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.80
PB Ratio	1.85
P/TBV Ratio	3.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.96
EV / Sales	32.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.39

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.

Current Ratio	2.63
Quick Ratio	1.73
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.49
Interest Coverage	-73.74

Financial Efficiency

Return on equity (ROE) is -44.25% and return on invested capital (ROIC) is -24.06%.

Return on Equity (ROE)	-44.25%
Return on Assets (ROA)	-20.81%
Return on Invested Capital (ROIC)	-24.06%
Return on Capital Employed (ROCE)	-42.53%
Revenue Per Employee	19.60M
Profits Per Employee	-162.33M
Employee Count	54
Asset Turnover	0.04
Inventory Turnover	1.10

Taxes

Income Tax	-153.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.76% in the last 52 weeks. The beta is 0.38, so Genesystem's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-48.76%
50-Day Moving Average	5,432.90
200-Day Moving Average	8,649.33
Relative Strength Index (RSI)	58.40
Average Volume (20 Days)	22,914

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genesystem had revenue of KRW 1.06 billion and -8.77 billion in losses. Loss per share was -1,289.13.

Revenue	1.06B
Gross Profit	-1.85B
Operating Income	-9.78B
Pretax Income	-9.56B
Net Income	-8.77B
EBITDA	-8.54B
EBIT	-9.78B
Loss Per Share	-1,289.13

Balance Sheet

The company has 4.02 billion in cash and 3.88 billion in debt, giving a net cash position of 139.45 million or 20.45 per share.

Cash & Cash Equivalents	4.02B
Total Debt	3.88B
Net Cash	139.45M
Net Cash Per Share	20.45
Equity (Book Value)	17.66B
Book Value Per Share	2,253.61
Working Capital	3.89B

Cash Flow

In the last 12 months, operating cash flow was -7.63 billion and capital expenditures -288.75 million, giving a free cash flow of -7.92 billion.

Operating Cash Flow	-7.63B
Capital Expenditures	-288.75M
Free Cash Flow	-7.92B
FCF Per Share	-1,161.08

Margins

Gross Margin	-174.96%
Operating Margin	-924.17%
Pretax Margin	-902.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genesystem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.98%
Shareholder Yield	n/a
Earnings Yield	-26.89%
FCF Yield	-24.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genesystem has an Altman Z-Score of 4.27 and a Piotroski F-Score of 3.

Altman Z-Score	4.27
Piotroski F-Score	3